Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-109,256
Closed -$601K 898
2025
Q1
$601K Buy
109,256
+9,013
+9% +$53.6K ﹤0.01% 702
2024
Q4
$595K Sell
100,243
-907
-0.9% -$5.62K ﹤0.01% 705
2024
Q3
$643K Buy
101,150
+6,262
+7% +$39.4K ﹤0.01% 763
2024
Q2
$593K Buy
94,888
+11,483
+14% +$80.3K ﹤0.01% 797
2024
Q1
$646K Sell
83,405
-443
-0.5% -$3.2K ﹤0.01% 783
2023
Q4
$610K Buy
83,848
+13,133
+19% +$103K ﹤0.01% 837
2023
Q3
$632K Sell
70,715
-122,115
-63% -$1.02M ﹤0.01% 744
2023
Q2
$1.38M Buy
192,830
+134,250
+229% +$983K 0.01% 771
2023
Q1
$450K Buy
+58,580
New +$521K ﹤0.01% 935

Other funds holding RES

Aviva's RES Position: Q2 2025 in Review

Aviva sold out of RPC Inc (RES) in Q2 2025, closing a stake of 109,256 shares — an estimated $601K sold.

Aviva first reported a position in RES in Q1 2023 and held it in 9 quarters. The position peaked at $1.38M in Q2 2023. 213 funds tracked by Wall St. Rank hold RES as of Q2 2025.

  • Aviva reported no remaining RPC Inc position as of Q2 2025 after selling out during the quarter.
  • Aviva sold 109,256 RPC Inc shares in Q2 2025, an estimated $601K.
  • Aviva first reported a position in RPC Inc in Q1 2023 and held it in 9 quarters.
  • Aviva's RPC Inc position peaked at $1.38M in Q2 2023.
  • 213 funds tracked by Wall St. Rank held RPC Inc as of Q2 2025.

Based on Aviva's 13F filing for Q2 2025, filed 7 Aug 2025.